What is the appropriate diagnostic work‑up and initial treatment for a patient with encephalitis who has multiple lesions on brain MRI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Encephalitis with Multiple MRI Lesions

Begin intravenous acyclovir 10 mg/kg every 8 hours immediately upon suspicion of encephalitis with multiple brain lesions, without waiting for diagnostic confirmation, as delayed treatment beyond 4 days increases mortality from 8% to 28%. 1, 2

Immediate Empiric Treatment

  • Start IV acyclovir within 6 hours of admission for any patient with suspected encephalitis, regardless of imaging findings, as HSV encephalitis is the most common treatable cause (25-40% of sporadic encephalitis cases) and early treatment is critical for survival. 3, 1, 2
  • Administer acyclovir at 10 mg/kg IV every 8 hours for adults and adolescents (20 mg/kg every 8 hours for children), adjusting for renal impairment. 1, 2
  • Continue empiric antibacterial coverage until bacterial infection is excluded by CSF analysis. 3
  • Treatment duration should be 14-21 days for confirmed HSV encephalitis. 1, 2

Diagnostic Work-Up (Performed Concurrently with Treatment)

Neuroimaging Priority

  • MRI with and without contrast is the imaging modality of choice, with approximately 90% sensitivity within 48 hours compared to only 25% sensitivity for CT. 1, 2
  • Look for characteristic patterns:
    • HSV encephalitis: Bilateral temporal lobe T2/FLAIR hyperintensities (present in >90% of cases), gyral edema, and involvement of cingulate gyrus. 3, 1, 2
    • Autoimmune encephalitis: Discrete hippocampal high signal with associated swelling (60% of VGKC-complex cases), may be bilateral or unilateral. 3
    • Other viral etiologies: Japanese B encephalitis affects thalamus/basal ganglia; enterovirus affects brainstem; VZV causes ischemic/hemorrhagic infarcts. 1
  • If MRI is unavailable, perform CT to exclude structural causes of raised intracranial pressure, but do not rely on CT to rule out encephalitis due to poor sensitivity. 1, 2

Lumbar Puncture and CSF Analysis

  • Perform lumbar puncture urgently (after imaging if concern for mass effect) with the following studies: 3, 1
    • HSV-1, HSV-2, and VZV PCR (sensitivity/specificity >95% when performed days 2-10 of illness). 2
    • Cell count with differential, protein, glucose, Gram stain, bacterial culture.
    • Opening pressure measurement.
    • Oligoclonal bands if autoimmune encephalitis suspected.
    • Consider enterovirus, parechovirus, CMV, HHV-6/7 PCR in immunocompromised patients. 2
  • A single negative HSV PCR does not rule out HSE, especially if obtained <72 hours after symptom onset—repeat LP in 24-48 hours if clinical suspicion remains high. 2
  • Typical viral CSF shows elevated protein with normal glucose and lymphocytic pleocytosis. 1

Additional Diagnostic Studies

  • Obtain neurology consultation immediately for all suspected encephalitis cases. 3
  • Perform EEG to detect periodic lateralizing epileptiform discharges (PLEDs) in temporal regions, present in ~80% of HSV encephalitis cases. 1, 2
  • Check serum autoimmune encephalitis panel (VGKC-complex, NMDA receptor antibodies) if subacute presentation, hyponatremia, orofacial dyskinesia, choreoathetosis, or faciobrachial dystonic seizures present. 3
  • Screen for malignancy in confirmed antibody-mediated encephalitis (thymoma, small cell lung cancer). 3
  • Blood tests: B12, HIV, rapid plasma reagin, ANA, Ro/La, TSH, aquaporin-4 IgG, cortisol, ACTH. 3

Management Based on Etiology

Confirmed or Suspected HSV Encephalitis

  • Continue IV acyclovir 10 mg/kg every 8 hours for 14-21 days. 1, 2
  • Monitor renal function closely and maintain adequate hydration to prevent acyclovir-induced crystalluria and obstructive nephropathy. 2
  • Even with treatment, mortality remains 25-28% at 18 months, and 20-60% of survivors develop neurological sequelae. 2

Autoimmune/Antibody-Mediated Encephalitis

  • Once bacterial and viral infections are excluded, initiate immunosuppression: 3
    • Mild-moderate cases: Oral prednisone 0.5-1 mg/kg daily. 3
    • Severe cases or oligoclonal bands present: IV methylprednisolone 1 g daily for 3-5 days plus IVIG 2 g/kg over 5 days. 3
  • For VGKC-complex antibody encephalitis: High-dose oral steroids (0.5 mg/kg/day) with antibody levels normalizing in 3-6 months, then taper over 12 months. 3
  • If limited improvement with steroids/IVIG, consider rituximab or plasmapheresis in consultation with neurology. 3
  • Remove any identified tumor (thymoma, small cell lung cancer). 3

Immune Checkpoint Inhibitor-Related Encephalitis

  • Permanently discontinue the checkpoint inhibitor for grade 3-4 toxicity. 3
  • Admit patient and initiate methylprednisolone 1 g daily for 3 days followed by oral corticosteroid taper. 3
  • Consider IVIG 2 g/kg over 5 days for severe or progressive symptoms. 3

Critical Pitfalls to Avoid

  • Never delay acyclovir while awaiting PCR or imaging results—this is the single most important factor affecting mortality and morbidity. 1, 2
  • Do not discontinue acyclovir based on a single negative CSF PCR, especially if obtained early (<72 hours) or if clinical suspicion remains high. 2
  • Do not use CT as the sole imaging modality to exclude encephalitis—its 25% sensitivity will miss most cases. 1, 2
  • Do not start corticosteroids before excluding infectious causes, as this may worsen viral or bacterial encephalitis. 3
  • In patients with multiple lesions, consider that this may represent either severe HSV encephalitis with extensive involvement, autoimmune encephalitis, or post-infectious ADEM—maintain broad differential until etiology confirmed. 3, 4, 5

Special Populations

  • Immunocompromised patients: Expand PCR testing to include CMV, HHV-6/7, HIV; consider ganciclovir, foscarnet, or cidofovir for CMV encephalitis; prolonged acyclovir treatment may be needed for HSV clearance. 3, 2
  • Renal impairment/dialysis patients: Significantly reduce acyclovir dosing based on creatinine clearance and maintain hydration. 6

References

Guideline

Approach to MRI Brain Suggestive of Early Features of Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach for Herpes Simplex Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A medical overview of encephalitis.

Neuropsychological rehabilitation, 2007

Research

Acute encephalitis - diagnosis and management.

Clinical medicine (London, England), 2018

Guideline

Encefalitis en Pacientes con Diálisis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.